207 related articles for article (PubMed ID: 15095141)
1. Kava does not display metabolic toxicity in a homogeneous cellular assay.
Zou L; Harkey MR; Henderson GL; Dike LE
Planta Med; 2004 Apr; 70(4):289-92. PubMed ID: 15095141
[TBL] [Abstract][Full Text] [Related]
2. Effects of kava (Kava-kava, 'Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes.
Zou L; Henderson GL; Harkey MR; Sakai Y; Li A
Phytomedicine; 2004; 11(4):285-94. PubMed ID: 15185840
[TBL] [Abstract][Full Text] [Related]
3. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
Weiss J; Sauer A; Frank A; Unger M
Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).
Unger M; Holzgrabe U; Jacobsen W; Cummins C; Benet LZ
Planta Med; 2002 Dec; 68(12):1055-8. PubMed ID: 12494328
[TBL] [Abstract][Full Text] [Related]
5. Kavalactones fail to inhibit alcohol dehydrogenase in vitro.
Anke J; Fu S; Ramzan I
Phytomedicine; 2006 Feb; 13(3):192-5. PubMed ID: 16428028
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
Anke J; Ramzan I
J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro.
Mathews JM; Etheridge AS; Valentine JL; Black SR; Coleman DP; Patel P; So J; Burka LT
Drug Metab Dispos; 2005 Oct; 33(10):1555-63. PubMed ID: 16033948
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).
Uebelhack R; Franke L; Schewe HJ
Pharmacopsychiatry; 1998 Sep; 31(5):187-92. PubMed ID: 9832350
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro, reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion.
Zou L; Harkey MR; Henderson GL
Planta Med; 2005 Feb; 71(2):142-6. PubMed ID: 15729622
[TBL] [Abstract][Full Text] [Related]
10. Kavalactones Yangonin and Methysticin induce apoptosis in human hepatocytes (HepG2) in vitro.
Tang J; Dunlop RA; Rowe A; Rodgers KJ; Ramzan I
Phytother Res; 2011 Mar; 25(3):417-23. PubMed ID: 20734326
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.
Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC
Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821
[TBL] [Abstract][Full Text] [Related]
12. Interaction of various Piper methysticum cultivars with CNS receptors in vitro.
Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W
Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human cytochrome P450 activities by kava extract and kavalactones.
Mathews JM; Etheridge AS; Black SR
Drug Metab Dispos; 2002 Nov; 30(11):1153-7. PubMed ID: 12386118
[TBL] [Abstract][Full Text] [Related]
14. Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.
Li Y; Mei H; Wu Q; Zhang S; Fang JL; Shi L; Guo L
Toxicol Sci; 2011 Dec; 124(2):388-99. PubMed ID: 21908763
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure.
Feltenstein MW; Lambdin LC; Ganzera M; Ranjith H; Dharmaratne W; Nanayakkara NP; Khan IA; Sufka KJ
Phytother Res; 2003 Mar; 17(3):210-6. PubMed ID: 12672148
[TBL] [Abstract][Full Text] [Related]
16. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in
Tang Y; Fields C
Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
[TBL] [Abstract][Full Text] [Related]
18. Determination of kavalactones in dried kava (Piper methysticum) powder using near-infrared reflectance spectroscopy and partial least-squares regression.
Gautz LD; Kaufusi P; Jackson MC; Bittenbender HC; Tang CS
J Agric Food Chem; 2006 Aug; 54(17):6147-52. PubMed ID: 16910700
[TBL] [Abstract][Full Text] [Related]
19. Isolation and synthesis of TNF-alpha release inhibitors from Fijian kawa (Piper methysticum).
Hashimoto T; Suganuma M; Fujiki H; Yamada M; Kohno T; Asakawa Y
Phytomedicine; 2003 May; 10(4):309-17. PubMed ID: 12809361
[TBL] [Abstract][Full Text] [Related]
20. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.
Robinson V; Bergfeld WF; Belsito DV; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; ; Andersen FA
Int J Toxicol; 2009; 28(6 Suppl):175S-88S. PubMed ID: 19966149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
